Notably, among approved anti-gout drugs, colchicine completely abrogated NCOA6 expression and speck formation in activated macrophages, suggesting that colchicine inhibits NLRP3 inflammasome activity by targeting NCOA6. The gene discussed is NLRP3; the disease is gout.